Image

Enhancing Palliative Care in ICU

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The aim of this study is to reduce the suffering in intensive care through palliative care consultations.

Description

This project investigates the effectiveness and cost-effectiveness of palliative care consultations in the Intensive care unit. Charité will implement the Working Package 2 "Europe-wide harmonized and recommended palliative care practice for ICU" of the approved HORIZON funding application EPIC, to which this ethics application refers.

An accompanying anonymous employee survey (doctors/nurses) is conducted once in the intervention phase and once in the control phase in all study centers (see secondary endpoints 57-68 and 71).

Eligibility

Patients

Inclusion Criteria:

  • Patients in ICU who can give consent and those who can not (via their authorized representative or legal guardian, also possible with delayed consent)
  • From 18 years
  • The leading cause of critical illness is not cancer
  • New admission on the participating ICU > 72h
  • Assessment of the need for palliative care by the in-charge physi-cian of the ICU, because (1) there is a significant disagreement about ICU treatment or (2) because the physician considers ther-apy limitations for the patient or (3) the physician considers a benefit from specialized PC consultation for ICU physician, nurse, or patient or family.

Exclusion Criteria:

  • Patient is moribund and is expected to die within the next 24h

Study cohort relatives:

Inclusion criteria:

  • At least one relative(s) of a patient. This may or may not be the legal representative, depending on national legislation.

Exclusion criteria:

  • Refusal by the relative
  • Refusal of the patient to participate in the intervention study
  • <18 years of age

Cohort of employees:

Inclusion criteria

  • Employed on the ITS as a doctor/nurse
  • Employed in the clinical center as a member of the palliative care consultation service

Exclusion criterion Refusal to participate

Study details

Palliative Care

NCT06605079

Charite University, Berlin, Germany

31 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.